ORBIMED ADVISORS LLC 13D and 13G filings for ALX Oncology Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:22 pm Sale |
2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO |
ORBIMED ADVISORS LLC | 0 0.000% |
-2,255,000 (Position Closed) |
Filing |
| 2024-02-14 7:45 pm Sale |
2023-12-31 | 13G | ALX Oncology Holdings Inc. ALXO |
ORBIMED ADVISORS LLC | 2,255,000 4.500% |
-11,000 (-0.49%) |
Filing |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | ALX Oncology Holdings Inc. ALXO |
ORBIMED ADVISORS LLC | 2,266,000 5.600% |
2,266,000 (New Position) |
Filing |